Evidence map›Paper›PMID 33187980›Full record

ArticleThe Journal of biological chemistry

Lacritin proteoforms prevent tear film collapse and maintain epithelial homeostasis.

Georgi A Georgiev, Mohammad Sharifian Gh, Jeff Romano, Karina L Dias Teixeira, Craig Struble, Denise S Ryan, Rose K Sia, Jay P Kitt, Joel M Harris, Ku-Lung Hsu and 5 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06854393 (Lacripep, a Novel Investigational Agent, for Corneal Wound Healing and Ocular Surface Homeostasis), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06854393 phase2recruitingnot on this map

Lacripep, a Novel Investigational Agent, for Corneal Wound Healing and Ocular Surface Homeostasis

TypeinterventionalSponsorHenry M. Jackson Foundation for the Advancement of Military MedicineRan2025 to 2027Enrolled88ConditionsCorneal Epithelial Wound HealingArms0.00025% Lacripep ophthalmic solution and Placebo
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Site-specific O-glycans influence lacritin structure and multimerization in tears.Protein science : a publication of the Protein Society · 2026
    Article
  2. Distinctive Lacritin Cleavage-Potentiated Bactericidal Alteration of thebioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Targeting Iron - Respiratory Reciprocity Promotes Bacterial Death.bioRxiv : the preprint server for biology · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Autophagy in the normal and diseased cornea.Experimental eye research · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Georgi A GeorgievInstitute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
Mohammad Sharifian GhDepartment of Cell Biology, University of Virginia, Charlottesville, Virginia, USA.
Jeff RomanoDepartment of Cell Biology, University of Virginia, Charlottesville, Virginia, USA.
Karina L Dias TeixeiraDepartment of Cell Biology, University of Virginia, Charlottesville, Virginia, USA.
Craig StrubleDrug Metabolism, Covance Laboratories Inc, Madison, Wisconsin, USA.
Denise S RyanWarfighter Refractive Eye Surgery Program and Research Center at Fort Belvoir, Fort Belvoir, Virginia, USA.
Rose K SiaWarfighter Refractive Eye Surgery Program and Research Center at Fort Belvoir, Fort Belvoir, Virginia, USA.
Jay P KittDepartment of Chemistry, University of Utah, Salt Lake City, Utah, USA.
Joel M HarrisDepartment of Chemistry, University of Utah, Salt Lake City, Utah, USA.
Ku-Lung HsuDepartment of Chemistry, University of Virginia, Charlottesville, Virginia, USA.
Adam LibbyDepartment of Chemistry, University of Virginia, Charlottesville, Virginia, USA.
Marc G OdrichDepartment of Ophthalmology, University of Virginia, Charlottesville, Virginia, USA.
Tatiana SuárezDepartment of Research, Development and Innovation, FAES FARMA, Bizkaia, Spain.
Robert L McKownDepartment of Integrated Science and Technology, James Madison University, Harrisonburg, Virginia, USA.
Gordon W LaurieDepartment of Cell Biology, University of Virginia, Charlottesville, Virginia, USA; Department of Ophthalmology, University of Virginia, Charlottesville, Virginia, USA; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA. Electronic address: glaurie@virginia.edu.
University of Virginia · USAlexander T. Augusta Military Medical Center · USUniversity of Utah · USCovance (United States) · USFaes Farma (Spain) · ESJames Madison University · USUniversity of Lisbon · PT

Funding

Tear Protein Microbial RegulationR01EY026171 · NEI · UNIVERSITY OF VIRGINIA · PI LAURIE, GORDON WILLIAM · 2016 to 2025
$3.6M
Lacritin Regulated Ocular Surface HomeostasisR01EY024327 · NEI · UNIVERSITY OF VIRGINIA · PI LAURIE, GORDON WILLIAM · 2014 to 2017
$1.8M
INTERNATIONAL RESEARCH REGISTRY NETWORK FOR SJOGERNS SYNDROME-268032636N01DE032636 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREENSPAN, JOHN · 2005 to 2006
–
NEI NIH HHS R01 EY024327NEI NIH HHS R01 EY026171NIDCR NIH HHS N01 DE032636
6 · The paper itself

Abstract

Lipids in complex, protein-enriched films at air/liquid interfaces reduce surface tension. In the absence of this benefit, the light refracting and immunoprotective tear film on eyes would collapse. Premature collapse, coupled with chronic inflammation compromising visual acuity, is a hallmark of dry eye disease affecting 7 to 10% of individuals worldwide. Although collapse seems independent of mutation (unlike newborn lung alveoli), selective proteome and possible lipidome changes have been noted. These include elevated tissue transglutaminase and consequent inactivation through C-terminal cross-linking of the tear mitogen lacritin, leading to significant loss of lacritin monomer. Lacritin monomer restores homeostasis via autophagy and mitochondrial fusion and promotes basal tearing. Here, we discover that lacritin monomer C-terminal processing, inclusive of cysteine, serine, and metalloproteinase activity, generates cationic amphipathic α-helical proteoforms. Such proteoforms (using synthetic peptide surrogates) act like alveolar surfactant proteins to rapidly bind and stabilize the tear lipid layer. Immunodepletion of C- but not N-terminal proteoforms nor intact lacritin, from normal human tears promotes loss of stability akin to human dry eye tears. Stability of these and dry eye tears is rescuable with C- but not N-terminal proteoforms. Repeated topical application in rabbits reveals a proteoform turnover time of 7 to 33 h with gradual loss from human tear lipid that retains bioactivity without further processing. Thus, the processed C-terminus of lacritin that is deficient or absent in dry eye tears appears to play a key role in preventing tear film collapse and as a natural slow release mechanism that restores epithelial homeostasis.

Indexed as

AnimalsDisease Models, AnimalDry Eye SyndromesEye ProteinsGlycoproteinsHumansMeibomian GlandsProtein IsoformsRabbitsTearsEye ProteinsGlycoproteinsLACRT protein, humanProtein Isoformselastic modulusepitheliumeyelacritinOAHFAprotein–lipid interactionproteoformproteolysisRaman spectroscopytears

Identifiers

PMID33187980
PMCPMC7948570
OpenAlexW3103861179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.